These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2451694)

  • 1. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity.
    Pincus SH; Shigeoka AO; Moe AA; Ewing LP; Hill HR
    J Immunol; 1988 Apr; 140(8):2779-85. PubMed ID: 2451694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of streptococcal antigens using monoclonal antibodies.
    Harris MC; Polin RA
    Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype restriction of idiotopes associated with human anti-streptococcal A carbohydrate antibodies.
    Emmrich F; Zenke G; Eichmann K
    Eur J Immunol; 1986 May; 16(5):542-6. PubMed ID: 2422045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
    Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
    Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen.
    Pincus SH; Smith MJ; Jennings HJ; Burritt JB; Glee PM
    J Immunol; 1998 Jan; 160(1):293-8. PubMed ID: 9551983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibody homodimers. Effect of valency on in vitro and in vivo antibacterial activity.
    Wolff EA; Esselstyn J; Maloney G; Raff HV
    J Immunol; 1992 Apr; 148(8):2469-74. PubMed ID: 1560202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific antibody prevents platelet aggregation induced by group B streptococci type III.
    Wood EG; Gray BM
    J Lab Clin Med; 1986 Apr; 107(4):322-6. PubMed ID: 3514775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of experimental group B streptococcal infection with hybridoma antibody.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological markers of the R4 protein of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of polysaccharide conformational epitopes by surface plasmon resonance.
    MacKenzie CR; Jennings HJ
    Methods Enzymol; 2003; 363():340-54. PubMed ID: 14579587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease.
    Hill HR; Kelsey DK; Gonzales LA; Raff HV
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S87-91. PubMed ID: 1728992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238.
    Borg-von Zepelin M; Grüness V
    J Med Vet Mycol; 1993; 31(1):1-15. PubMed ID: 8483055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of type-specific antibody to streptococcus pyogenes by affinity chromatography.
    Havlícek J; Kühnemund O; Srámek J; Pokorný J
    Immunobiology; 1979 Aug; 156(1-2):48-56. PubMed ID: 396225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared idiotope on monoclonal anti-Ia.7 antibodies reactive with determinants in a structural domain of the I-E molecules.
    Devaux C; Labit C; Marchetto S; Pierres M
    J Immunol; 1984 Mar; 132(3):1353-60. PubMed ID: 6198390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc region-dependence of IgG3 anti-streptococcal group A carbohydrate antibody functional affinity. I. The effect of temperature.
    Greenspan NS; Dacek DA; Cooper LJ
    J Immunol; 1988 Dec; 141(12):4276-82. PubMed ID: 3058803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.